150 related articles for article (PubMed ID: 9566644)
1. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: effects on bone metabolism amongst premenopausal women.
Knudsen N; Faber J; Sierbaek-Nielsen A; Vadstrup S; Sørensen HA; Hegedüs L
J Intern Med; 1998 Feb; 243(2):149-54. PubMed ID: 9566644
[TBL] [Abstract][Full Text] [Related]
2. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
4. Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
Faber J; Overgaard K; Jarløv AE; Christiansen C
Thyroidology; 1994 Apr; 6(1):27-32. PubMed ID: 7536445
[TBL] [Abstract][Full Text] [Related]
5. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
[TBL] [Abstract][Full Text] [Related]
8. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
9. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
Marcocci C; Golia F; Vignali E; Pinchera A
J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
[TBL] [Abstract][Full Text] [Related]
10. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
12. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.
Gam AN; Jensen GF; Hasselstrøm K; Olsen M; Nielsen KS
J Endocrinol Invest; 1991 Jun; 14(6):451-5. PubMed ID: 1774441
[TBL] [Abstract][Full Text] [Related]
13. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level.
Faber J; Perrild H; Johansen JS
J Clin Endocrinol Metab; 1990 Jan; 70(1):49-55. PubMed ID: 2294139
[TBL] [Abstract][Full Text] [Related]
14. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone.
Taelman P; Kaufman JM; Janssens X; Vandecauter H; Vermeulen A
Clin Endocrinol (Oxf); 1990 Jul; 33(1):107-17. PubMed ID: 2401091
[TBL] [Abstract][Full Text] [Related]
15. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Eur J Endocrinol; 1996 Jun; 134(6):702-9. PubMed ID: 8766939
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
18. Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study.
Carella C; Mazziotti G; Rotondi M; Del Buono A; Zito G; Sorvillo F; Manganella G; Santini L; Amato G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):507-13. PubMed ID: 12354133
[TBL] [Abstract][Full Text] [Related]
19. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.
Faber J; Jensen IW; Petersen L; Nygaard B; Hegedüs L; Siersbaek-Nielsen K
Clin Endocrinol (Oxf); 1998 Mar; 48(3):285-90. PubMed ID: 9578817
[TBL] [Abstract][Full Text] [Related]
20. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
